Elsevier

Journal of Hepatology

Volume 72, Issue 5, May 2020, Pages 990-1002
Journal of Hepatology

Review
The landscape of gene mutations in cirrhosis and hepatocellular carcinoma

https://doi.org/10.1016/j.jhep.2020.01.019Get rights and content

Summary

Chronic liver disease and primary liver cancer are a massive global problem, with a future increase in incidences predicted. The most prevalent form of primary liver cancer, hepatocellular carcinoma, occurs after years of chronic liver disease. Mutations in the genome are a causative and defining feature of all cancers. Chronic liver disease, mostly at the cirrhotic stage, causes the accumulation of progressive mutations which can drive cancer development. Within the liver, a Darwinian process selects out dominant clones with selected driver mutations but also leaves a trail of passenger mutations which can be used to track the evolution of a tumour. Understanding what causes specific mutations and how they combine with one another to form cancer is a question at the heart of understanding, preventing and tackling liver cancer. Herein, we review the landscape of gene mutations in cirrhosis, especially those paving the way toward hepatocellular carcinoma development, that have been characterised by recent studies capitalising on technological advances in genomic sequencing. With these insights, we are beginning to understand how cancers form in the liver, particularly on the background of chronic liver disease. This knowledge may soon lead to breakthroughs in the way we detect, diagnose and treat this devastating disease.

Keywords

HCC
Cancer
Genomics
Oncogenes
Chronic liver disease
Evolution

Cited by (0)

Author names in bold designate shared co-first authorship

View Abstract